Selected References:
- AbbVie Inc. 2023. Orlissa product label. Available at: https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=a86757b3-09c5-fd3b-1223-244e94f50a66&type=display. Accessed 23 September 2025.
- AbbVie Inc. 2023. Oriahnn product label. Available at: https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=99f6eee7-7e52-6999-7eb8-488d06dd1710&type=display. Accessed 23 September 2025.
- Archer DF, et al. 2019. Elagolix suppresses ovulation in a dose-dependent manner: results from a 3-month, randomized study in ovulatory women. J Clin Endocrinol Metab 105(3): 821-832.
